Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
View ORCID ProfileKartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C. McDonald, Cynthia R. Cherry, Meghan Shea, Mark S. Huberman, Paul A. VanderLaan, Glen J. Weiss, Paul R. Walker, Daniel B. Costa, Deepa Rangachari
doi: https://doi.org/10.1101/2020.03.31.20048637
Kartik Sehgal
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
M.B.B.S.Anushi Bulumulle
bDivision of Hematology and Oncology, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA
cVidant Medical Center, Greenville, NC 27834, USA
MDHeather Brody
bDivision of Hematology and Oncology, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA
cVidant Medical Center, Greenville, NC 27834, USA
MDRitu R. Gill
dDepartment of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MD, MPHShravanti Macherla
bDivision of Hematology and Oncology, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA
cVidant Medical Center, Greenville, NC 27834, USA
MDAleksandra Qilleri
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
Danielle C. McDonald
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
NP, MSNCynthia R. Cherry
cVidant Medical Center, Greenville, NC 27834, USA
MSN-AGNPMeghan Shea
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MDMark S. Huberman
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MDPaul A. VanderLaan
eDepartment of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MD, PhDGlen J. Weiss
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MD, MBAPaul R. Walker
bDivision of Hematology and Oncology, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA
MD, FACPDaniel B. Costa
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MD, PhDDeepa Rangachari
aDivision of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
MDArticle usage
Posted May 31, 2020.
Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C. McDonald, Cynthia R. Cherry, Meghan Shea, Mark S. Huberman, Paul A. VanderLaan, Glen J. Weiss, Paul R. Walker, Daniel B. Costa, Deepa Rangachari
medRxiv 2020.03.31.20048637; doi: https://doi.org/10.1101/2020.03.31.20048637
Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R. Gill, Shravanti Macherla, Aleksandra Qilleri, Danielle C. McDonald, Cynthia R. Cherry, Meghan Shea, Mark S. Huberman, Paul A. VanderLaan, Glen J. Weiss, Paul R. Walker, Daniel B. Costa, Deepa Rangachari
medRxiv 2020.03.31.20048637; doi: https://doi.org/10.1101/2020.03.31.20048637
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2771)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12423)
- Forensic Medicine (10)
- Gastroenterology (786)
- Genetic and Genomic Medicine (4288)
- Geriatric Medicine (396)
- Health Economics (703)
- Health Informatics (2769)
- Health Policy (1025)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (405)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4066)
- Nursing (218)
- Nutrition (602)
- Oncology (2145)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (78)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6671)
- Radiology and Imaging (1457)
- Respiratory Medicine (888)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (171)